ATC codes
B Blood and blood forming organs
B01 Antithrombotic agents
B02 Antihemorrhagics
B03 Antianemic preparations
B05 Blood substitutes and perfusion solutions
B06 Other hematological agents
A • B • C • D • G • H • QI • J • L • M • N • P • R • S • V

ATC code B01 Antithrombotic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup B01 is part of the anatomical group B Blood and blood forming organs.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QB01...^[2]

Contents 1 B01A Antithrombotic agents 1.1 B01AA Vitamin K antagonists 1.2 B01AB Heparin group 1.3 B01AC Platelet aggregation inhibitors excluding heparin 1.4 B01AD Enzymes 1.5 B01AE Direct thrombin inhibitors 1.6 B01AX Other antithrombotic agents 2 References

[edit] B01A Antithrombotic agents

[edit] B01AA Vitamin K antagonists

B01AA01 Dicoumarol

B01AA02 Phenindione

B01AA03 Warfarin

B01AA04 Phenprocoumon

B01AA07 Acenocoumarol

B01AA08 Ethyl biscoumacetate

B01AA09 Clorindione

B01AA10 Diphenadione

B01AA11 Tioclomarol

[edit] B01AB Heparin group

B01AB01 Heparin

B01AB02 Antithrombin III

B01AB04 Dalteparin

B01AB05 Enoxaparin

B01AB06 Nadroparin

B01AB07 Parnaparin

B01AB08 Reviparin

B01AB09 Danaparoid

B01AB10 Tinzaparin

B01AB11 Sulodexide

B01AB12 Bemiparin

B01AB51 Heparin, combinations

[edit] B01AC Platelet aggregation inhibitors excluding heparin

B01AC01 Ditazole

B01AC02 Cloricromen

B01AC03 Picotamide

B01AC04 Clopidogrel

B01AC05 Ticlopidine

B01AC06 Acetylsalicylic acid

B01AC07 Dipyridamole

B01AC08 Carbasalate calcium

B01AC09 Epoprostenol

B01AC10 Indobufen

B01AC11 Iloprost

B01AC13 Abciximab

B01AC15 Aloxiprin

B01AC16 Eptifibatide

B01AC17 Tirofiban

B01AC18 Triflusal

B01AC19 Beraprost

B01AC21 Treprostinil

B01AC30 Combinations

[edit] B01AD Enzymes

B01AD01 Streptokinase

B01AD02 Alteplase

B01AD03 Anistreplase

B01AD04 Urokinase

B01AD05 Fibrinolysin

B01AD06 Brinase

B01AD07 Reteplase

B01AD08 Saruplase

B01AD09 Ancrod

B01AD10 Drotrecogin alfa (activated)

B01AD11 Tenecteplase

B01AD12 Protein C

[edit] B01AE Direct thrombin inhibitors

B01AE01 Desirudin

B01AE02 Lepirudin

B01AE03 Argatroban

B01AE04 Melagatran

B01AE05 Ximelagatran

B01AE06 Bivalirudin

B01AE07 Dabigatran etexilate

[edit] B01AX Other antithrombotic agents

B01AX01 Defibrotide

B01AX04 Dermatan sulfate

B01AX05 Fondaparinux

B01AX06 Rivaroxaban

[edit] References

v • d • e Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) Antiplatelet drugs Glycoprotein IIb/IIIa inhibitors Abciximab • Eptifibatide • Tirofiban ADP receptor/P2Y12 inhibitors (Thienopyridines) Clopidogrel • Ticlopidine • Prasugrel Prostaglandin analogue (PGI2) Beraprost • Prostacyclin • Iloprost • Treprostinil COX inhibitors Acetylsalicylic acid/Aspirin # • Aloxiprin • Carbasalate calcium Other Ditazole • Cloricromen • Dipyridamole • Indobufen • Picotamide • Triflusal Anticoagulants Vitamin K antagonists (inhibit II, VII, IX, X) coumarins: Acenocoumarol • Coumatetralyl • Dicoumarol (Dicumarol) • Ethyl biscoumacetate • Phenprocoumon • Warfarin 1,3-Indandiones: Clorindione • Diphenadione • Phenindione other: Tioclomarol Factor Xa inhibitors (with some II inhibition) Heparin group/ glycosaminoglycans/ (bind antithrombin) low molecular weight heparin (Bemiparin, Certoparin, Dalteparin, Enoxaparin, Nadroparin, Parnaparin, Reviparin, Tinzaparin) oligosaccharides (Fondaparinux, Idraparinux) heparinoid (Danaparoid, Sulodexide, Dermatan sulfate) Direct Xa inhibitors xabans (Apixaban, Otamixaban, Rivaroxaban) Direct thrombin (II) inhibitors bivalent: Hirudin (Bivalirudin, Lepirudin, Desirudin) univalent: Argatroban • Dabigatran • Melagatran • Ximelagatran Other Defibrotide • Ramatroban • Antithrombin III • Protein C (Drotrecogin alfa) Thrombolytic drugs/ fibrinolytics plasminogen activators: TPA (Alteplase, Reteplase, Tenecteplase) • UPA (Urokinase, Saruplase) • Streptokinase # • Anistreplase • Monteplase other serine endopeptidases: Ancrod • Fibrinolysin Brinase Non-medicinal Citrate • EDTA • Oxalate #WHO-EM. ‡Withdrawn from market. CLINICAL TRIALS: †Phase III. §Never to phase III